News

Silexion Therapeutics (SLXN) announced compelling preclinical data demonstrating the efficacy of its next-generation RNAi ...
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; ...
As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, or other spine-related symptoms. Lab tests confirmed she had severe anemia; ...
This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...
Zacks Investment Research on MSN6dOpinion
3 Communication Stocks Likely to Surpass Industry Conundrums
HLIT, Ooma, Inc. OOMA and AudioCodes Ltd. AUDC are likely to gain in the long run as demand for scalable infrastructure for ...
The Zacks Wireless Non-US industry appears well-poised to benefit from healthy demand trends stemming from the increasing ...
These achievements will lead to advancements in understanding the mechanism behind β-cell proliferation in order to maintain normal blood glucose levels. In addition, it is anticipated that this ...
Cells are the smallest units of life. But even within the same tissue or organ, they are not all identical. New variations arise continuously during cell proliferation. While genetic mutations alter ...
Life on Earth possesses an exceptional ability to self-reproduce, which, even on a simple cellular level, is driven by ...